Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change
11/09/26	€0.0460	-4.17%
10/09/26	€0.0480	0.00%
09/09/26	€0.0480	+4.35%
08/09/26	€0.0460	0.00%
07/09/26	€0.0460	0.00%

Delayed Quote Deutsche Boerse AG

More quotes

Delayed Deutsche Boerse AG 07:20:02 11/09/2026 BST			5-day change	1st Jan Change
0.0460 ^EUR	-4.17%		+4.35%	+263.64%

Market Cap	144K 168K 136K 124K 232K 16.02M 234K 1.62M 623K 8.13M 629K 615K 25.81M	P/E 2021	-3.89x	P/E 2022	-53x
Enterprise Value	9.87M 11.47M 9.31M 8.48M 15.85M 1.1B 16M 111M 42.67M 556M 43.08M 42.14M 1.77B	EV / Sales 2021	14.1x	EV / Sales 2022	1.22x
Free-Float	100%	Yield 2021 *	-	Yield 2022	-

Markets		Quality
Deutsche Boerse AG	PA8K	End-of-day quote
Deutsche Boerse AG	PA8	Delayed
Tradegate	PA8	Real-time
OTC Markets	PAIOF	Delayed
Börse Stuttgart	PA8	Delayed
Boerse Muenchen	PA8	Real-time

1 week	+4.35%
Current month	+4.35%
1 month	+3.23%
3 months	-10.28%
6 months	-27.27%
Current year	+263.64%

1 week	0.05	0.05
1 month	0.04	0.05
3 years	0	4.82
5 years	0	18.22
10 years	0	34.75

Paion Share Price Deutsche Boerse AG

Stocks

PA8

DE000A0B65S3

Biotechnology & Medical Research

Valuation : Paion

Chart: Paion

Latest news : Paion

Press Releases : Paion

News in other languages : Paion

Quotes and Performance

Price Extremes

Managers and Directors : Paion

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Manager	Title	Age	Since
Tilmann Bur CEO	Chief Executive Officer	62	31/08/2023
Sebastian Werner DFI	Director of Finance/CFO	-	31/05/2022

Director	Title	Age	Since
Karin Louise Dorrepaal BRD	Director/Board Member	65	30/09/2012
Hans Tanner BRD	Director/Board Member	75	31/05/2017
Markus Guilherme Dieken BRD	Director/Board Member	-	21/05/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PAION	-4.17%	+4.35%	+433.33%	-99.04%	398K
LONZA GROUP AG	+0.69%	-8.08%	-3.88%	+10.58%	46.05B
REVOLUTION MEDICINES, INC.	-2.08%	-3.57%	+402.72%	+533.09%	43.59B
IQVIA HOLDINGS INC.	+0.12%	-5.27%	+39.94%	+20.50%	42.35B
BEONE MEDICINES AG	-2.62%	-5.76%	+8.88%	+77.44%	38.86B
CELLTRION, INC.	-1.26%	-3.37%	+11.87%	+40.55%	32.24B
ASCENDIS PHARMA A/S	+0.16%	-3.65%	-	-	17.16B
MEDPACE HOLDINGS, INC.	-0.54%	-1.72%	+22.34%	+115.10%	16.28B
EUROFINS SCIENTIFIC SE	+0.25%	-2.23%	+11.09%	+31.23%	14.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.92%	-6.94%	+78.12%	+36.68%	13.03B
Average	-0.80%	-4.70%	+111.60%	+85.13%	29.32B
Weighted average by Cap.	-0.85%	-5.04%	+86.47%	+128.51%

	2021	2022
Net sales	7.13M 8.29M 6.73M 6.13M 11.45M 792M 11.56M 80.1M 30.83M 402M 31.13M 30.45M 1.28B	33.25M 38.66M 31.37M 28.58M 53.42M 3.7B 53.91M 374M 144M 1.87B 145M 142M 5.95B
Net income	-21.79M -25.33M -20.56M -18.73M -35.01M -2.42B -35.32M -245M -94.22M -1.23B -95.13M -93.05M -3.9B	-579K -673K -546K -498K -930K -64.37M -939K -6.51M -2.5M -32.65M -2.53M -2.47M -104M
Net Debt	13.77M 16.01M 12.99M 11.84M 22.12M 1.53B 22.33M 155M 59.55M 776M 60.12M 58.81M 2.47B	9.72M 11.31M 9.17M 8.36M 15.62M 1.08B 15.76M 109M 42.05M 548M 42.46M 41.53M 1.74B